216 related articles for article (PubMed ID: 27754786)
1. Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.
Pilbrow AP; Lewis KA; Perrin MH; Sweet WE; Moravec CS; Tang WH; Huising MO; Troughton RW; Cameron VA
Endocrinology; 2016 Dec; 157(12):4865-4874. PubMed ID: 27754786
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor.
Pal K; Swaminathan K; Xu HE; Pioszak AA
J Biol Chem; 2010 Dec; 285(51):40351-61. PubMed ID: 20966082
[TBL] [Abstract][Full Text] [Related]
3. Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide.
Pérez-García S; Juarranz Y; Carrión M; Gutiérrez-Cañas I; Margioris A; Pablos JL; Tsatsanis C; Gomariz RP
J Cell Physiol; 2011 Dec; 226(12):3261-9. PubMed ID: 21360527
[TBL] [Abstract][Full Text] [Related]
4. Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.
Ryabinin AE; Tsoory MM; Kozicz T; Thiele TE; Neufeld-Cohen A; Chen A; Lowery-Gionta EG; Giardino WJ; Kaur S
Alcohol; 2012 Jun; 46(4):349-57. PubMed ID: 22444954
[TBL] [Abstract][Full Text] [Related]
5. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
[TBL] [Abstract][Full Text] [Related]
6. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.
Fukuda T; Takahashi K; Suzuki T; Saruta M; Watanabe M; Nakata T; Sasano H
J Clin Endocrinol Metab; 2005 Aug; 90(8):4671-8. PubMed ID: 15914529
[TBL] [Abstract][Full Text] [Related]
7. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.
Bale TL; Picetti R; Contarino A; Koob GF; Vale WW; Lee KF
J Neurosci; 2002 Jan; 22(1):193-9. PubMed ID: 11756502
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent islets.
Huising MO; Pilbrow AP; Matsumoto M; van der Meulen T; Park H; Vaughan JM; Lee S; Vale WW
Endocrinology; 2011 Jan; 152(1):138-50. PubMed ID: 21106875
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing factor (CRF) system localization in human fetal heart.
Chouridou E; Lambropoulou M; Koureta M; Zarouchlioti C; Balgouranidou I; Nena E; Papadopoulos N; Chatzaki E
Hormones (Athens); 2016; 15(1):55-64. PubMed ID: 27377597
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor family peptide signaling in feline bladder urothelial cells.
Hanna-Mitchell AT; Wolf-Johnston A; Roppolo JR; Buffington TC; Birder LA
J Endocrinol; 2014 Jul; 222(1):113-21. PubMed ID: 24829219
[TBL] [Abstract][Full Text] [Related]
11. Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin.
Parham KL; Zervou S; Karteris E; Catalano RD; Old RW; Hillhouse EW
Endocrinology; 2004 Aug; 145(8):3971-83. PubMed ID: 15142984
[TBL] [Abstract][Full Text] [Related]
12. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
[TBL] [Abstract][Full Text] [Related]
13. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of urocortins1-3 mRNA in human umbilical vein endothelial cells.
Kageyama K; Hanada K; Suda T
Regul Pept; 2009 Jun; 155(1-3):131-8. PubMed ID: 19254747
[TBL] [Abstract][Full Text] [Related]
15. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity.
Chen AM; Perrin MH; Digruccio MR; Vaughan JM; Brar BK; Arias CM; Lewis KA; Rivier JE; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2620-5. PubMed ID: 15701705
[TBL] [Abstract][Full Text] [Related]
16. Urocortins: Actions in health and heart failure.
Rademaker MT; Richards AM
Clin Chim Acta; 2017 Nov; 474():76-87. PubMed ID: 28887029
[TBL] [Abstract][Full Text] [Related]
17. Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro.
Jin L; Zhang Q; Guo R; Wang L; Wang J; Wan R; Zhang R; Xu Y; Li S
J Mol Endocrinol; 2011 Oct; 47(2):219-27. PubMed ID: 21765100
[TBL] [Abstract][Full Text] [Related]
18. Urocortins are present in the rat testis.
Lee S; Braden B; Kang SS; Rivier C
Neuropeptides; 2011 Apr; 45(2):131-7. PubMed ID: 21256589
[TBL] [Abstract][Full Text] [Related]
19. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice.
Kaur S; Li J; Stenzel-Poore MP; Ryabinin AE
Alcohol Clin Exp Res; 2012 Feb; 36(2):369-76. PubMed ID: 21895713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
